Article

Software uses trend, event analyses to measure progression

San Diego-The newest version of proprietary software (Guided Progression Analysis, Carl Zeiss Meditec) to measure the progression of glaucoma combines event and trend analyses and permits faster and more quantitative evaluation of progressive change in visual field, said Donald L. Budenz, MD, MPH, professor of ophthalmology, Bascom Palmer Eye Institute, University of Miami Miller School of Medicine.

San Diego—The newest version of proprietary software (Guided Progression Analysis, Carl Zeiss Meditec) to measure the progression of glaucoma combines event and trend analyses and permits faster and more quantitative evaluation of progressive change in visual field, said Donald L. Budenz, MD, MPH, professor of ophthalmology, Bascom Palmer Eye Institute, University of Miami Miller School of Medicine.

“And it builds in this concept of needing to confirm progression not only on just a single field but on two fields,” he added.

Dr. Budenz advised clinical correlation, however.

“Not everything that appears like progression on visual fields is going to be glaucoma, so one needs to rule out other factors…to explain progression on [the software],” he said.

Use of the software requires a particular, newer perimeter (Humphrey Field Analyzer II-i, Carl Zeiss Meditec), Dr. Budenz said. The program “adjusts for the reduced hill of vision in many of our elderly patients who develop cataract, and it works with the old threshold fields from the early and mid 1990s and the newer [Swedish interactive threshold algorithm] fields from the late 1990s,” he said.

The software was developed based on parameters for change used in the Early Manifest Glaucoma Treatment study, Dr. Budenz said. The new program determines change at specific points by comparing information from the pattern deviation plot instead of information from the total deviation plot as used in glaucoma change probability software. In theory, he said, this ability eliminates the confounding factor of change caused by diffuse depression of the visual field, which can occur in eyes with cataract, for instance.

The new software’s trend analysis capability “plots a new [visual field] index against a patient’s age and shows the rate of change thus far and then provides a prediction of future loss if the patient’s course is not changed,” Dr. Budenz said.

“Unlike mean deviation, it weighs central points more than peripheral points…and plots the age of the patient on the x axis rather than time,” he added.

The resulting graph can be helpful in explaining progression to patients, Dr. Budenz said.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) ASCRS 2025: Advancing vitreous care with Inder Paul Singh, MD
(Image credit: Ophthalmology Times) The Residency Report: Study provides new insights into USH2A target end points
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
Patricia Buehler, MD, MPH, founder and CEO of Osheru, talks about the Ziplyft device for noninvasive blepharoplasty at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Bonnie An Henderson, MD, on leveraging artificial intelligence in cataract refractive surgery
(Image credit: Ophthalmology Times) ASCRS 2025: Gregory Moloney, FRANZO, FRCSC, on rotational stability
© 2025 MJH Life Sciences

All rights reserved.